Celecoxib
Back to searchMolecule Structure
Scientific Name
Celecoxib
Description of the Drug
Celecoxib is an NSAID used to treat osteoarthritis, rheumatoid arthritis, acute pain, menstrual symptoms, and to reduce polyps is familial adenomatous polyposis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00482
http://www.drugbank.ca/drugs/DB00482
Brand Name(s)
Celebra, Celebrex, Celecoxib, Elyxyb, Onsenal
Company Owner(s)
Cipla Ltd, Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Watson Laboratories Inc, Nanjing Simcere Dongyuan Pharmaceutical Co Ltd, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Of New York Llc, Biodelivery Sciences International Inc, Torrent Pharmaceuticals Ltd, Micro Labs Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cyclooxygenase-2 | SINGLE PROTEIN | INHIBITOR | CHEMBL230 |
Clinical Trial(s)
Unichem Links
| Atlas | celecoxib | ||||||
| SureChEMBL | SCHEMBL3708 | ||||||
| PharmGKB | PA448871 | ||||||
| Human Metabolome Database | HMDB0005014 | ||||||
| DrugBank | DB00482 | ||||||
| PubChem: Thomson Pharma | 14755918 | ||||||
| PubChem | 2662 | ||||||
| Mcule | MCULE-4750749400 | ||||||
| LINCS | LSM-2032 | ||||||
| Nikkaji | J833.239H | ||||||
| PDBe | CEL | ||||||
| BindingDB | 11639 | ||||||
| EPA CompTox Dashboard | DTXSID0022777 | ||||||
| DrugCentral | 568 | ||||||
| Brenda | 83080 | 154370 | 153386 | 1809 | 69450 | ||
| ChemicalBook | CB54842250 | CB91267649 | CB74842249 | CB7444681 | CB44842248 | CB93313564 | CB14842247 |
| Guide to Pharmacology | 2892 | ||||||
| rxnorm | CELEBREX | ELYXYB | CELECOXIB | ||||
| PubChem: Drugs of the Future | 12015009 | ||||||
| KEGG Ligand | C07589 | ||||||
| ChEBI | 41423 | ||||||
| ZINC | ZINC000002570895 |
